Co-diagnostics | 10-Q:季度報表
Co-diagnostics | 8-K:Co-Diagnostics, Inc. 公佈2024年第一季度財務業績
Co-diagnostics | 4:持股變動聲明-高管 Abbott Richard David
Co-diagnostics | 4:持股變動聲明-高管 Brown Brian Lee
Co-diagnostics | 4:持股變動聲明-高管 Egan Dwight H
Co-diagnostics | 4:持股變動聲明-董事 Durenard Eugene
Co-diagnostics | 4:持股變動聲明-董事 NELSON JAMES B
Co-diagnostics | 4:持股變動聲明-董事 MURPHY TED
Co-diagnostics | 4:持股變動聲明-董事 SERBIN RICHARD S
Co-diagnostics | 3:首次持股聲明-高管 Abbott Richard David
Co-diagnostics | 8-K:重大事件
Co-diagnostics | 10-K:年度報表
Co-diagnostics | 8-K:重大事件
Co-diagnostics | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(5.82%)
Co-diagnostics | 4:持股變動聲明-董事 Durenard Eugene
Co-diagnostics | 4:持股變動聲明-董事 SERBIN RICHARD S
Co-diagnostics | 4:持股變動聲明-董事 NELSON JAMES B
Co-diagnostics | 4:持股變動聲明-董事 MURPHY TED
Co-diagnostics | 4:持股變動聲明-首席財務官 Brown Brian Lee
Co-diagnostics | 4:持股變動聲明-首席執行官 Egan Dwight H
暫無數據